https://publichealth.nyu.edu/events-news/events/2022/03/18/name-only-covid-19-vaccines-and-failed-promises-global-solidarity
In this webinar, Dr. Boghuma Titanji, Infectious Diseases Fellow at Emory University School of Medicine, will discuss COVID-19 global vaccination efforts, where things currently stand with vaccinations across various low-resource countries, what has led to this situation, and what is needed to attain global vaccine equity. Dr.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00893-X/fulltext
To address COVID-19 vaccine scarcity, Ivan Sisa and colleagues1 justify placebo-controlled trials in low-income and middle-income countries (LMICs), arguing that these countries have "less capacity to negotiate and purchase vaccines than do high-income countries" and that the global shortage can be overcome with more vaccine producers coming from such trials.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653338/
With the rise of several resistant variants, this work argues that public health policy experts demand a greater need for global solidarity in vaccine access. This is not only important ethically, but it is also a pragmatic response. Keywords: coronavirus, COVID‐19, global health, TRIPS waiver, vaccine equity, vaccine nationalism, vaccines.

https://www.nature.com/articles/s41541-023-00625-x
Throughout the COVID-19 pandemic, global inequality in the access to vaccines has been highlighted as a moral injustice and a medical danger. Medical experts agree that global vaccine inequity

https://pubmed.ncbi.nlm.nih.gov/34585430/
Abstract. The COVID-19 pandemic is one of the most disruptive social, political and economic crises of the modern era. In today's interconnected world, the pandemic shows how quickly infectious disease outbreaks can spread across continents. Since the initial outbreak, the introduction of several vaccines has brought hope to a virus-weary world

https://www.ohchr.org/en/press-releases/2022/10/solidarity-covid-19-vaccines-key-step-bridging-rights-divide-between-rich
There is a breakdown in public trust enabling the propelling of false and misinformed theories on (COVID-19) vaccines and their effects," Okafor said. "Under international human rights law, States have a duty to cooperate, including in terms of vaccine solidarity to ensure the fullest enjoyment of human rights by everyone around the globe."

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(21)00895-3.pdf
The global COVID-19 vaccine roll-out might be the largest public health exercise ever done. COVAX, the vaccines access pillar of the COVID-19 Tools Accelerator, supported by WHO, UNICEF, and others, expects to deliver two billion doses to 190 countries in 1 year. At present, 13 vaccines have received approval in various jurisdictions.

https://www.mckinsey.com/industries/healthcare/our-insights/finding-solidarity-in-an-effort-to-vaccinate-the-world
As long as COVID-19 is out there, it's a threat.Unless vaccine supplies are shared more equitably, it's estimated that the world's poorest countries will not be able to reach a vaccination rate of 60 percent until 2023 or later. 1 Atthar Mirza and Emily Rauhala, "Here's just how unequal the global coronavirus vaccine rollout has been," Washington Post, May 6, 2021, washingtonpost.com.

https://www.who.int/news/item/23-09-2021-global-leaders-commit-further-support-for-global-equitable-access-to-covid-19-vaccines-and-covax
Leaders pledge financing, dose donations, support for country readiness and delivery and scale up of global manufacturing, to enable equitable access to COVID-19 vaccinesTo improve access for lower-income economies, the United States will contribute an additional 500 million doses of Pfizer vaccine to be delivered through COVAX, beginning in 2022, and Sweden will provide an additional SEK 2.1

https://journals.library.columbia.edu/index.php/bioethics/article/view/12042
Photo by Spencer Davis on Unsplash ABSTRACT Current conceptions of solidarity impose a morality and sacrifice that did not prevail in the case of COVID-19 vaccine distribution. Notably, the vaccine distribution disparity revealed that when push came to shove, in the case of global distribution, self-interested persons reached inward rather than reaching out, prioritized their needs, and acted

https://www.chathamhouse.org/sites/default/files/2021-07/2021-07-14-solidarity-response-covid-19-pandemic-rahman-shepherd-et-al_0_0.pdf
from masks to vaccines, that are needed to fight COVID-19.2 At a global level, WHO has played a significant role in defining solidarity and shaping it as a concept relevant to pandemic response efforts. It was communicated as a choice between policies and actions that aimed to unite, and policies and actions that sowed division and competition.

https://www.tandfonline.com/doi/full/10.1080/16544951.2022.2075137
Global distribution of vaccines against COVID-19. In July 2020 five national leaders, including the Prime ministers of New Zealand, Spain, Sweden and Tunisia and the Presidents of South Korea and South Africa, published an article in Washington Post with the headline 'The international community must guarantee equal global access to COVID-19 vaccine.'

https://academic.oup.com/cid/article/75/Supplement_1/S86/6583150
Global access to coronavirus disease 2019 (COVID) vaccines has been terribly unequal, raising urgent questions about how to respond to the resulting inequalities in vulnerability and the rising insecurities in protection caused by the evolution of severe acute respiratory syndrome coronavirus 2 in the bodies of the world's unvaccinated populations [].

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hpm.3341
The SARS-CoV-2 (Severe Acute Respiratory Syndrome 2) hereafter COVID-19 pandemic has exposed the fragility of global health systems. Over a year has passed since the initial outbreak of COVID-19 in Wuhan, Hubei province, China. As the world cautiously reopens, several vaccines have been approved based on their antigenic responses to COVID-19.

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-trial-of-covid-19-vaccines
The Solidarity Trial Vaccines (STV) is an international, multi center, multi vaccine, adaptive, shared placebo, event driven, individually randomized controlled clinical trial that aims to evaluate the efficacy and safety of promising new COVID-19 vaccines.. The primary objective is to evaluate the effect of each vaccine on reducing the rate of virologically confirmed COVID-19 disease

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003772
The COVID-19 pandemic highlights the grave inequity and inadequacy of the global preparedness and response to serious emerging infections. The establishment of the Coalition for Epidemic Preparedness Innovations (CEPI) in 2018, the Access to COVID-19 Tools Accelerator (ACT-A), and the COVID-19 Vaccines Global Access (COVAX) Facility in April 2020 and the rapid development of COVID-19 vaccines

https://theconversation.com/vaccine-diplomacy-how-some-countries-are-using-covid-to-enhance-their-soft-power-155697
The COVID-19 pandemic has given rise to various new, repurposed or newly popular terms. The newest entry to the pandemic lexicon might be " vaccine diplomacy ", with some countries using their

https://www.cnn.com/2020/12/13/world/coronavirus-vaccine-developing-world-intl/index.html
Wesley Wheeler, President of Global Healthcare at United Parcel Service (UPS), holds up a sample of the vial that will be used to transport the Pfizer COVID-19 vaccine as he testifies during a

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118613/
To address COVID-19 vaccine scarcity, Ivan Sisa and colleagues 1 justify placebo-controlled trials in low-income and middle-income countries (LMICs), arguing that these countries have "less capacity to negotiate and purchase vaccines than do high-income countries" and that the global shortage can be overcome with more vaccine producers coming from such trials.

https://www.unicef.org/supply/stories/dose-sharing-how-global-solidarity-can-help-curb-pandemic
There are immediate and obvious benefits to dose sharing. By increasing the speed and scale of vaccine coverage globally, dose sharing can help limit the spread of COVID-19 and prevent new variants from emerging. These mutations have the potential to spread globally even in countries where relatively higher immunization coverage has been achieved.

https://www.who.int/initiatives/covid-19-technology-access-pool/solidarity-call-to-action
Solidarity Call to Action. To realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data. The single most important priority of the global community is to stop the COVID-19 pandemic in its tracks; to halt its rapid transmission and reverse the trend of consequential global distress.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265252/
The equitable distribution of COVID-19 vaccines is one of the most important tests of global cooperation that the world has faced in recent decades. Collectively, global leaders failed that crucible abysmally, creating a 'vaccine apartheid' that divided the world according to income into countries with widespread access and those without.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376271/
Vaccine charity centrally involves the humanitarian work of the global health agencies and donor governments that have organized the COVAX program as an antidote to unequal access. Despite their many promises, however, both vaccine diplomacy and vaccine charity have failed to deliver the doses needed to overcome the global vaccination gap.

https://www.latimes.com/world-nation/story/2024-06-20/macron-and-african-leaders-push-for-vaccines-for-africa-after-covid-19-exposed-inequalities
Many African leaders and advocacy groups say Africa was unfairly locked out of access to COVID-19 treatment tools, vaccines and testing equipment — that many richer countries bought them up in